Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt ...

ETFs such as The Schwab US Dividend ETF can be useful, but a 'DIY' approach can help you outperform. Here are 3 of the best ...

Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...

Summit County's Department of Health announced clinics in Akron are now offering the new Pfizer COVID-19 vaccine.

The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The ...

Among patients with alopecia areata, prior use of any treatment type did not affect the long-term treatment response of ritlecitinib.

On Thursday, Starboard CEO Jeff Smith, accused Pfizer of skulduggery in forcing the pair to withdraw their support. He claimed that Read and D’Amelio had been contacted by company representatives, who ...

(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...

While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030.